Summary
Hyperfine, Inc. (HYPR) Q2 2026 Earnings Call Transcript
Hyperfine, Inc. (HYPR) Q2 2026 Earnings Call Transcript
Hyperfine Q2 Earnings Call Highlights
Hyperfine NASDAQ: HYPR reported second-quarter revenue of $3.9 million, up approximately 45% from a year earlier, as the portable MRI company cited growth across hospital, neurology office and international markets.
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Hyperfine Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BN Beth Nauman UNIVEST FINANCIAL Corp. | 10,752 | $7,702 | $8,546.76 | $844.76 | 10.97% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 11,910 | $16,075 | $9,467.26 | -$6,607.74 | -41.11% |
| BG Bart Gancher Intech Investment Management LLC | 17,661 | $24,372.18 | $16,866.25 | -$7,505.93 | -30.8% |
| LJB Laura J. Bornheimer GWN SECURITIES Inc. | 274,677 | $370,814 | $257,097.67 | -$113,716.33 | -30.67% |
 Joseph Castro Nuveen LLC | 102,831 | $138,822 | $81,246.77 | -$57,575.23 | -41.47% |
Hyperfine Inc. (HYPR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Hyperfine Inc. ever had a stock split?
Hyperfine Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Maria Degois Sainz CEO | NASDAQ (NMS) Exchange | 44916K106 CUSIP |
| US Country | 102 Employees | - Last Dividend | - Last Split | 27 Jan 2021 IPO Date |
Overview
Hyperfine, Inc., established in 2014 and located in Guilford, Connecticut, operates within the medical device industry, focusing primarily on advancing magnetic resonance imaging (MRI) technology. As a pioneering company in the United States, Hyperfine is dedicated to improving patient care by making MRI technologies more accessible and convenient, particularly in critical care situations. Their innovative approach includes developing portable MRI systems aimed at transforming neuroimaging practices by offering solutions that can be utilized across various medical settings, including intensive care units (ICUs) and stroke accredited facilities. Additionally, Hyperfine places a strong emphasis on supporting its products through comprehensive direct sales and distributor networks.
Products and Services
Swoop Portable MR Imaging System: Hyperfine's flagship product, the Swoop, revolutionizes brain neuroimaging by offering a portable solution that can be easily deployed within different clinical environments. This system is designed to facilitate immediate and convenient brain scans, aiding in faster diagnosis and treatment decisions for critical patients. The Swoop's mobility reduces the need for costly and time-consuming patient transports to traditional MRI facilities, bringing the technology directly to the patient's bedside.
Support and Technical Assistance Services: Understanding the importance of reliable and uninterrupted operation of medical equipment, Hyperfine provides extensive support and technical assistance for their MRI products. This service ensures that healthcare facilities can maximize the utility of the Swoop Portable MR Imaging System with minimal downtime, reinforcing Hyperfine’s commitment to enhancing patient care through innovative technology solutions.
